Ulcerative Colitis Treatment Studies

If you are looking for clinical trials for ulcerative colitis you have come to the right place! As researchers, our goal is to discover new therapies and information about Inflammatory Bowel Disease (IBD), but most importantly, provide an alternate therapy that helps YOU. We welcome you to the IBD Research Team and encourage you to look at the studies below that you may qualify for. We will update this site periodically, so keep checking this page for new studies. If you have ANY questions or are interested in participating please feel free to call (734) 615-4843 or e-mail higginsSCteam@umich.edu We hope to hear from you soon!


M16-067 – risankizumab UC

A phase 2b/3 multicenter, randomized, double-blind, placebo-controlled induction study to evaluate the efficacy and safety of risankizumab in subjects with moderately to severely active ulcerative colitis who have failed prior biologic therapy

Enrollment Status: TBA

Study Coordinator: Andy Brosius

Drug: IV induction / injection under the skin for maintenance


CNTO – Janssen

Phase 3 clinical studies of guselkumab (CNTO 1959), a fully human anti-IL23p19 monoclonal antibody, in patients with moderately to severely active Crohn's disease who have demonstrated an inadequate response to or failure to tolerate previous conventional therapies or biologic therapies

Enrollment status: TBA

Study Coordinator: Jennifer Dixon

Drug: oral tablet